Last Price
3.80
Today's Change
+0.17 (4.68%)
Day's Change
3.63 - 3.95
Trading Volume
13,897
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Indranil Dey Mr. Indranil Dey
Full Time Employees: 10 10
IPO Date: 2021-11-10 2021-11-10
CIK: 0001704287 0001704287
ISIN: US0956333019 US0956333019
CUSIP: 095633103 095633103
Beta: 0.73 0.73
Last Dividend: 0.00 0.00
Dcf Diff: -8.93 -8.93
Dcf: 13.54 13.54
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.